Continuous Monitoring Given that the long-term safety of semaglutide GLP-1 for weight management is still under investigation, our team of healthcare professionals at Noor Medical Spa monitors patients closely for any adverse effects, especially gastrointestinal and pancreatic events
Months 12-18: full recovery Most people who experienced telogen effluvium on GLP-1 medications report near-complete recovery within 12-18 months of onset, provided they maintained adequate nutrition and the shedding was truly telogen effluvium (not androgenetic alopecia or another condition)
If NICE recommends them in future, access would likely follow similar criteria to Wegovy injections requiring referral through a specialist weight management service, strict BMI thresholds, and evidence that other weight loss approaches have already been tried
At the class level, both have a GI-dominant profile (nausea, vomiting, diarrhoea) that concentrates at dose escalation
Protein bands were detected using an ECL kit and chemiluminescence imaging, and band intensities were analyzed with Image J